Interfacial self-assembly of amphiphilic conjugated block copolymer into 2D nanotapes

Size-Tunable Semiconducting 2D Nanorectangles from Conjugated Polyenyne Homopolymer Synthesized via Cascade Metathesis and Metallotropy Polymerization

Size-tunable semiconducting two-dimensional (2D) nanosheets from conjugated homopolymers are promising materials for easy access to optoelectronic applications, but it has been challenging due to the low solubility of conjugated homopolymers. Herein, we report size-tunable and uniform semiconducting 2D nanorectangles via living crystallization-driven self-assembly (CDSA) of a fully conjugated polyenyne homopolymer prepared by cascade metathesis and metallotropy (M&M) polymerization. The resulting polyenyne with enhanced solubility successfully underwent living CDSA via biaxial growth mechanism, thereby producing 2D nanorectangles with sizes precisely tuned from 0.1 to 3.0 μm² with narrow dispersity mostly less than 1.1 and low aspect ratios less than 3.1. Furthermore, living CDSA produced complex 2D block comicelles with different heights from various degrees of polymerization (DPs) of unimers. Based on diffraction analyses and DFT calculations, we proposed an interdigitating packing model with an orthorhombic crystal lattice of semiconducting 2D nanorectangles.

Confined Self-Assembly of Block Copolymers within Emulsion Droplets: A Perspective

When the self-assembly of block copolymers (BCPs) occurs within organic emulsion droplets in the aqueous phase, the strong structural frustration of BCP chains causes the formation of a series of well-regulated BCP particles that cannot be obtained from the self-assembly of BCPs in the bulk state or solution. In this Perspective, we review the recent progress of the self-assembly of BCPs confined in emulsion droplets. The governing factors of the structure and morphology of the as-prepared BCP particles are summarized. In addition, the applications of the as-prepared BCP particles in photonic crystals and drug release are discussed. Finally, we also give a forward-looking perspective on future challenges in this field.

Self-Assembly of Polystyrene-b-poly(2-vinylpyridine)/Chloroauric Acid at the Liquid/Liquid Interface

The self-assembly of polystyrene-block-poly(2-vinylpyridine) at the liquid/liquid interface has been systematically investigated to develop a series of primary morphologies of the aggregates. The block copolymers self-assembled into large areas of nanodot arrays, parallel nanostrands, layered films, parallel nanobelts, honeycomb monolayers, and foams by reacting with chloroauric acid, depending on the molecular structure of the block copolymers and the amount of chloroauric acid. The formation of the first four ordered structures resulted from interfacial adsorption and self-assembly, and nucleation and epitaxial growth. The latter two structures were attributed to the water hole templating effect and spontaneous interfacial emulsification, respectively. This work provides insight into the self-assembly behavior of block copolymers at the interface and provides a facile approach for fabricating functional structures.

Romidepsin and metformin nanomaterials delivery on streptozocin for the treatment of Alzheimer's disease in animal model

Brain insulin signal anomalies are implicated in Alzheimer's disease (AD) pathology. In this background, metformin, an insulin sensitizer's neuroprotective effectiveness, has been established in the prior findings. In the present investigation, combining an epigenetic modulator, romidepsin, and metformin will improve the gene expressions of neurotrophic factors and reduce AD-associated biochemical and cellular changes by loading them mainly into a nanocarrier surface-modified framework for improved therapeutic effectiveness and bioavailability. In the present investigation, the mediated intra-cerebroventricular streptozocin (3 mg/kg) AD of the model was loaded with metformin and romidepsin into a poloxamer stabilized polymer nanocarrier system. Free combination drug therapy (Romidepsin 25 mg/kg and metformin 5 mg/kg) reduced biochemical and cellular variations over three weeks, respectively, compared to either free treatment (Romidepsin 50 mg/kg and metformin 10 mg/kg). The nanoformulations (Romidepsin 25 mg/kg and Metformin 5 mg/kg), as shown by enhanced significantly reduce stress and high neurotrophic factors, has also exerted superior neurological effectiveness than the free combination of drugs. Eventually, through the Poloxamer stable polymeric nanocarrier framework, the synergistic neuroprotective efficacy of metformin and romidepsin has improved.

Combinational dual drug delivery system to enhance the care and treatment of gastric cancer patients

Gastric cancer is a frequently occurring cancer with high mortality each year worldwide. Finding new and effective therapeutic strategy against human gastric cancer is still urgently required. Hence, we have established a new method to achieve treatment-actuated modifications in a tumor microenvironment by utilizing synergistic activity between two potential anticancer drugs. Dual drug delivery of gemcitabine (GEM) and Camptothecin-11 (CPT-11) exhibits a great anti-cancer potential, as GEM enhances the effect of CPT-11 treatment of human gastric cells by providing microenvironment stability. However, encapsulation of GEM and CPT-11 obsessed by poly(lactic-co-glycolic acid) (PLGA)-based nanoparticles (NPs) is incompetent owing to unsuitability between the binary free GEM and CPT-11 moieties and the polymeric system. Now, we display that CPT-11 can be prepared by hydrophobic covering of the drug centers with dioleoylphosphatidic acid (DOPA). The DOPA-covered CPT-11 can be co-encapsulated in PLGA NPs alongside GEM to stimulate excellent anticancer property. The occurrence of the CPT-11 suggestively enhanced the encapsulations of GEM into PLGA NPs (GEM-CPT-11 NPs). Formation of the nanocomposite (GEM-CPT-11 NPs) was confirmed by FTIR and X-ray spectroscopic techniques. Further, the morphology of GEM NPs, CPT-11 NPs, and GEM-CPT-11 NPs and NP size was examined by transmission electron microscopy (TEM), respectively. Furthermore, GEM-CPT-11 NPs induced significant apoptosis in human gastric NCI-N87 and SGC-791 cancer cells in vitro. The morphological observation and apoptosis were confirmed by the various biochemical assays (AO-EB, nuclear staining, and annexin V-FITC). In addition, evaluation of the hemolysis assay with erythrocytes of human shows excellent biocompatibility of free GEM, free CPT-11, GEM NPs, CPT-11 NPs, and GEM-CPT-11 NPs. The results suggest that GEM-CPT-11 NPs are one of the promising nursing cares for human gastric cancer therapeutic candidates worthy of further investigations.